Assessing Individual and Community Needs
CDC.gov (2022) reports that about 900,000 people in the USA are affected by venous thromboembolism (VTE) annually. Furthermore, approximately 60,000 to 100,000 VTE-associated deaths are recorded annually (CDC.gov, 2022). Twenty-five percent of these mortalities occur suddenly (CDC.gov, 2022). Inadequately managed VTE has a poor prognosis, and it is estimated that about ten to thirty percent of patients succumb to the condition within the first month after diagnosis (CDC.gov, 2022). Also, approximately thirty-three percent of patients with VTE have a post-thrombotic syndrome that lowers their quality of life (CDC.gov, 2022).
Gao et al. (2022) report that the global prevalence of VTE in the intensive care unit ranges from about 0.4 percent to 82 percent. Various factors increase the risk of ICU-related VTE. They include prolonged indwelling catheters, severe acute respiratory conditions such as COVID-19, older adults, smoking history, and mechanical ventilation. Nahum et al. (2020) report that end-stage kidney failure, liver disease, and increased levels of D-dimer increase the risk of VTE among patients with COVID-19. Regardless of the etiology, VTE predisposes patients to complications such as pulmonary embolism and post-thrombotic syndrome (PTS) (CDC.gov, 2022). PTS presents with pain, discolored body parts, swelling, and ulcerations or scaling (CDC.gov, 2022).
My research findings will address patient and community needs by lowering the prevalence and incidence of ICU-associated VTE. By so doing, VTE-associated complications and mortalities will be lowered. Firstly, venous thromboembolism prophylaxis will ensure that the best pharmacological interventions are used to reduce the risk of VTE (Li et al., 2022). Secondly, risk stratification will identify patients’ risk of VTE and guide the formulation of individualized venous thromboembolism prophylaxis (Li et al., 2022). Ultrasound screening will facilitate the identification of VTE based on timely interventions to avert complications.
Do you need any help for completing your assignment ? Contact us at eminencepapers.com. We endeavor to provide you with excellent service.
References
CDC.gov. (2022). Data and Statistics on Venous Thromboembolism. https://www.cdc.gov/ncbddd/dvt/data.html
Gao, X., Zeng, L., Wang, H., Zeng, S., Tian, J., Chen, L., & Peng, T. (2022). Prevalence of Venous Thromboembolism in Intensive Care Units: A Meta-Analysis. Journal of Clinical Medicine, 11(22), 6691. https://doi.org/10.3390/jcm11226691
Li, L., Zhen, J., Huang, L., Zhou, J., Yao, L., Xu, L., Zhang, W., Zhang, G., Chen, Q., Cheng, B., Gong, S., Cai, G., Jiang, R., & Yan, J. (2022). The risk factors for deep venous thrombosis in critically ill older adult patients: a subgroup analysis of a prospective, multicenter, observational study. BMC Geriatrics, 22(1), 1–11. https://doi.org/10.1186/s12877-022-03599-y
Nahum, J., Morichau-Beauchant, T., Daviaud, F., Echegut, P., Fichet, J., Maillet, J. M., & Thierry, S. (2020). Venous Thrombosis among Critically Ill Patients with Coronavirus Disease 2019 (COVID-19). JAMA Network Open, 3(5), 3–6. https://doi.org/10.1001/
ORDER A PLAGIARISM-FREE PAPER HERE
We’ll write everything from scratch
Question 
Discuss the individual and/or community needs as it relate to the reason for your capstone research inquiry. Why do you believe your research inquiry/findings will address the identified needs that prompted your inquiry?
Assessing Individual and Community Needs
Length: A minimum of 250 words, not including references
Citations: At least one high-level scholarly reference in APA from within the last 5 years